- Home
- FCO vs LTRN Comparison
FCO vs LTRN Comparison
Compare FCO & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FCO | LTRN |
|---|---|---|
| Founded | 1991 | 2013 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.4M | 38.7M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | FCO | LTRN |
|---|---|---|
| Price | $3.10 | $2.94 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $25.00 |
| AVG Volume (30 Days) | ★ 100.1K | 52.5K |
| Earning Date | 01-01-0001 | 11-12-2025 |
| Dividend Yield | ★ 14.96% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.43 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $12.30 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.73 | $2.55 |
| 52 Week High | $6.63 | $5.74 |
Technical Indicators
Market Signals| Indicator | FCO | LTRN |
|---|---|---|
| Relative Strength Index (RSI) | 57.92 | 35.89 |
| Support Level | $3.11 | $3.32 |
| Resistance Level | $3.26 | $3.20 |
| Average True Range (ATR) | 0.09 | 0.21 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 50.91 | 5.04 |
Price Performance
Historical ComparisonAbout FCO abrdn Global Income Fund Inc.
abrdn Global Income Fund Inc is a closed-end, non-diversified management investment company. The Fund's principal investment objective is to provide high current income by investing predominantly in fixed-income securities. As a secondary investment objective, the Fund seeks capital appreciation, but only when consistent with its principal investment objective. It invests in Government Bonds & Corporate Bonds, and its investments are divided into three categories, Developed Markets, Investment Grade Developing Markets and Sub-Investment Grade Developing Markets.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.